Condition
Fibrosis; Skin
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Enrolling By Invitation1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06791564Not ApplicableCompleted
Minimally Invasive Active Release of Septa Bands for Cellulite and Connective Tissue Release for Fibrosis Treatment in Body Contouring Surgery
NCT07345052Recruiting
Western Sweden Systemic Sclerosis Project
NCT07149506Phase 3Enrolling By Invitation
Oral or Topical Catechins for Radiation Dermatitis
NCT04286698Not ApplicableCompleted
Two Different Physiotherapy Programs in Lymphedema Following Head and Neck Cancer Treatment
Showing all 4 trials